Rottapel, Rebecca E.
Stopka, Thomas J.
Friedmann, Peter D.
Hoskinson, Randall A.
Englander, Daviana
Calhoun, Nicole
Senst, Thomas
Gudas, Christopher
Koutoujian, Peter J.
Farabee, David https://orcid.org/0000-0002-0398-205X
Funding for this research was provided by:
National Institute on Drug Abuse (1R01DA056446)
Article History
Received: 4 June 2025
Accepted: 2 October 2025
First Online: 27 October 2025
Declarations
:
: David Farabee has received study medication from Indivior and Alkermes. Peter D. Friedmann has served as a member of the scientific advisory board for Indivior.